Biological Products, (No Diagnostic Substances) · DE · CIK 882796
Biocryst Pharmaceuticals develops and commercializes medicines for rare diseases like HAE
Comparable business profile · signals at a glance
In the 90 days to Mar 20, 2026: 2 sold $2.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Heggie TheresaDirector | Sell | 49,933 | $10.11 | $505K |
| Mar 16, 2026 | Barnes Alane PChief Legal Officer | Sell | 150,000 | $9.15 | $1.4M |
| Dec 22, 2025 | Barnes Alane PChief Legal Officer | Sell | 21,773 | $7.65 | $167K |
| Dec 15, 2025 | Barnes Alane PChief Legal Officer | Sell | 21,210 | $7.65 | $162K |
| Dec 3, 2025 | Barnes Alane PChief Legal Officer | Sell | 19,770 | $7.65 | $151K |
| Dec 2, 2025 | Barnes Alane PChief Legal Officer | Sell | 50,906 | $7.21 | $367K |
| Dec 1, 2025 | Barnes Alane PChief Legal Officer | Sell | 91,004 | $7.10 | $646K |
| Nov 13, 2025 | Sanders MachelleDirector | Sell | 9,600 | $7.14 | $69K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.